VAERS reports by lot

GSK Varicella/Shingles lot EK279: VAERS reports

78 VAERS reports list lot EK279 as a GSK Varicella/Shingles vaccine, received between 2018-02-03 and 2019-11-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
78
Reports
4%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)9034%
Injection-site / Local reaction5420%
Dermatological (non-injection-site)2610%
Neurological239%
Musculoskeletal207%
Allergic / Anaphylactic176%
Cardiac / Cardiovascular114%
Gastrointestinal104%
Respiratory83%
Psychiatric / Neuropsychiatric73%
Thrombotic / Hematological21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas13
New York7
Florida6
California5
Arizona4
Oklahoma3
Washington3
Virginia2
Connecticut2
Minnesota2
New Hampshire2
South Carolina2

Reports by month received

2018-026
2018-0310
2018-0423
2018-0516
2018-067
2018-075
2018-085
2018-092
2018-111
2019-041
2019-081
2019-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.